The genotoxicity test package of plant protection products evaluated in the European Union and their respective evaluation in the United States: Outcomes of the evaluation for future considerations

被引：0

|

作者：

Papadaki, P.

Karabetsou, N.

Machera, K.

机构：

来源：

TOXICOLOGY LETTERS | 2010年 / 196卷

关键词：

D O I：

10.1016/j.toxlet.2010.03.360

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

收藏

页码：S100 / S101

页数：2

相关论文

共 17 条

[1] Evaluation and authorisation of plant protection products within the European Union
Meynecke, JO
[J]. JOURNAL OF APPLIED BOTANY AND FOOD QUALITY-ANGEWANDTE BOTANIK, 2004, 78 (03): : 157 - 160
[2] Assessment of PBTs in the European Union: A critical assessment of the proposed evaluation scheme with reference to plant protection products
Solomon K.
Matthies M.
Vighi M.
[J]. Environmental Sciences Europe, 2013, 25 (01)
[3] Introduction to special section: Drug evaluation in the United States, Canada, and the European Union
Yelin, EH
Katz, PP
[J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (01): : 3 - 3
[4] Reflections on Bird and Mammal Risk Assessment for Plant Protection Products in the European Union: Past, Present, and Future
Brooks, Amy C.
Fryer, Mike
Lawrence, Alan
Pascual, Juan
Sharpk, Rachel
[J]. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2017, 36 (03) : 565 - 575
[5] Analysis and comparative evaluation of expedited programs for gene therapy products: insights from the United States, the European Union, Japan, and South Korea
Jeong, Hyeokgyo
Purja, Sujata
Kim, Eunyoung
[J]. GENE THERAPY, 2024, 31 (5-6) : 242 - 254
[6] Analysis and comparative evaluation of expedited programs for gene therapy products: insights from the United States, the European Union, Japan, and South Korea
Hyeokgyo Jeong
Sujata Purja
Eunyoung Kim
[J]. Gene Therapy, 2024, 31 : 242 - 254
[7] Toxicological evaluation of microbial secondary metabolites in the context of European active substance approval for plant protection products
Paege, Norman
Feustel, Sabrina
Marx-Stoelting, Philip
[J]. ENVIRONMENTAL HEALTH, 2024, 23 (01)
[8] Opportunities to improve the electronic reporting system for adverse drug reactions in Mexico: A comparative evaluation with the United States of America and the European Union
Cano-Sandoval, Miguel A.
Lopez-Armas, Gabriela C.
Perfecto-Avalos, Yocanxochitl
Vazquez-Alvarez, Alan O.
Brennan-Bourdon, Lorena M.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (11) : 1523 - 1526
[9] TOXICOLOGICAL EVALUATION OF GENETICALLY ENGINEERED PLANT PESTICIDES - POTENTIAL DATA REQUIREMENTS OF THE UNITED-STATES-ENVIRONMENTAL-PROTECTION-AGENCY
MCCLINTOCK, JT
SJOBLAD, RD
ENGLER, R
[J]. ACS SYMPOSIUM SERIES, 1992, 484 : 41 - 47
[10] A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation
Coppens, Delphi G. M.
de Wilde, Sofieke
Guchelaar, Henk J.
De Bruin, Marie L.
Leufkens, Hubert G. M.
Meij, Pauline
Hoekman, Jarno
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 517 - 517